1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Schneider Electric SE
  6. News
  7. Summary
    SU   FR0000121972

SCHNEIDER ELECTRIC SE

(SU)
  Report
Real-time Euronext Paris  -  11:37 2022-08-08 am EDT
132.38 EUR   +0.18%
08:55aSCHNEIDER ELECTRIC : To download or not to download, and just drive to the theater? What's more sustainable may surprise you
PU
07:55aSCHNEIDER ELECTRIC : Bernstein keeps a Sell rating
MD
04:14aASCO Power Technologies Showcases Healthcare Solutions at the NCHEA 70th Annual Conference
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Schneider Electric : How an Uninterruptible Power Supply Supports Pharma 4.0

06/30/2022 | 05:03pm EDT

A reliable, continual power supply is critical to any industrial process to prevent costly interruptions. But nowhere is it more critical than in a sterile environment that handles aseptic / Biological manufacturing. An interruption can lead to discarding entire batches of products, potentially costing producers hundreds of thousands of dollars. That's why an industrial uninterruptible power supply (UPS) or backup power is important to provide continuous and quality power to avoid unplanned downtime and production losses.

The aseptic / Biological manufacturing process

The aseptic / Biological process is extremely delicate. It involves a manufacturing process under meticulously managed sterile conditions. Any failure in the process can lead to product deviations and even the contamination of an entire batch in production. Various factors, such as pressure regimes, temperature, humidity, and airborne particulates, can cause contamination of product if managed incorrectly. Likewise, the ability to properly manage the power supply can lead to a failure of the environmental factors.

Regulated process environments are so sensitive, therefore it's not enough to simply avoid an outage. That's a given in any industrial setting, with an outage leading to production lines drawing to a halt. Voltage deviations and current fluctuations can result in the environmental conditions being out of specification, machines overheating, and reducing the life of an asset.

Even a minor voltage fluctuation or disturbance can ruin a batch in the aseptic / Biological process. Complicating matters, some interruptions require notifying regulators. When that happens, a regulator must determine if the batch is safe to use or needs to be discarded. If the batch can move forward, it still costs anywhere from $10,000 to $20,000 to have it inspected. However, if it is discarded, the loss is much greater.

Achieving power quality

Pharmaceutical companies that experience production issues may end up with product shortages, damaging their reputation. Many facilities can experience outages due to extreme weather or system faults caused by aging infrastructure. Voltage dips and current fluctuations can also occur if utilities change their power generation mix to include micro-generation and renewables.

Power distribution systems are under more pressure than ever as the industry adopts Pharma 4.0, undergoing digital transformation to leverage automation and drive efficiencies. However, while digitization delivers significant benefits, it also places an extra burden on electrical systems.

It's estimated that 30% to 40% of business downtime is connected to power quality issues. Biopharma companies, therefore, must take concrete steps to avoid these issues. And that means investing in robust uninterruptable power supply systems (UPS) that help protect aseptic / Biological processing as well as other critical systems that affect production quality, such as HVAC. A reliable power supply for HVAC systems is just about as important as running the aseptic / Biological process itself.

Uninterruptible power supply ― More than just backup power

A UPS addresses power quality issues in several ways, including the use of Power Factor Correction (PFC) that regulates input current and an Inverter that conditions output voltage. UPS systems provide isolation and protection against voltage spikes, over and under-voltage, frequency variations, and issues with harmonics and power factors. The systems come with batteries for short-term power backup when needed. If an outage outlasts battery life, the UPS can perform a graceful shutdown.

Schneider Electric offers a variety of industrial UPS systems to help biopharma producers protect the aseptic process, comply with regulatory mandates, and avoid the types of failures that incur substantial recovery costs and damaged reputations. Learn more about an industrial UPS system's benefits and how it can significantly improve operations and prevent production losses. Also, access more information about solutions for Life Sciences Industries of the Future to see how technological innovation can improve your business.

Disclaimer

Schneider Electric SE published this content on 30 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 June 2022 21:02:09 UTC.


© Publicnow 2022
All news about SCHNEIDER ELECTRIC SE
08:55aSCHNEIDER ELECTRIC : To download or not to download, and just drive to the theater? What's..
PU
07:55aSCHNEIDER ELECTRIC : Bernstein keeps a Sell rating
MD
04:14aASCO Power Technologies Showcases Healthcare Solutions at the NCHEA 70th Annual Confere..
AQ
08/03SCHNEIDER ELECTRIC RANKS #1 FOR THIR : Europe Top 15
GL
08/03SCHNEIDER ELECTRIC RANKS #1 FOR THIR : Europe Top 15
GL
08/02IFA 2022 : Keynote - Smart Home is the Smart Option for a Sustainable Future
AQ
08/01SCHNEIDER ELECTRIC : Deutsche Bank reiterates its Neutral rating
MD
08/01Schneider Electric Expands PowerLogic(TM) PFC Platform to North American Markets
AQ
08/01Schneider Electric unveils SE Retail Pavilion
AQ
08/01SCHNEIDER ELECTRIC LAUNCHES ITS OMNI : Schneider Electric (SE) Retail Pavilion
AQ
More news
Analyst Recommendations on SCHNEIDER ELECTRIC SE
More recommendations
Financials
Sales 2022 33 006 M 33 731 M 33 731 M
Net income 2022 3 686 M 3 767 M 3 767 M
Net Debt 2022 6 971 M 7 124 M 7 124 M
P/E ratio 2022 20,4x
Yield 2022 2,34%
Capitalization 73 487 M 75 101 M 75 101 M
EV / Sales 2022 2,44x
EV / Sales 2023 2,29x
Nbr of Employees 128 000
Free-Float 94,3%
Chart SCHNEIDER ELECTRIC SE
Duration : Period :
Schneider Electric SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SCHNEIDER ELECTRIC SE
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 132,38 €
Average target price 153,62 €
Spread / Average Target 16,0%
EPS Revisions
Managers and Directors
Jean-Pascal Tricoire Chairman & Chief Executive Officer
Hilary Maxson Chief Financial Officer & Executive Vice President
Premraj Krishnakutty Vice President-Research & Development
Léo Apotheker Director
Linda I. Knoll Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SCHNEIDER ELECTRIC SE-23.24%74 501
KEYENCE CORPORATION-22.63%100 168
EATON CORPORATION PLC-13.99%59 207
EMERSON ELECTRIC CO.-2.78%53 683
NIDEC CORPORATION-28.08%41 311
ROCKWELL AUTOMATION, INC.-27.69%29 117